Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
Abstract Human malaria affects the vast majority of the world’s population with the Plasmodium falciparum species causing the highest rates of morbidity and mortality. With no licensed vaccine and leading candidates achieving suboptimal protection in the field, the need for an effective immunoprophy...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e05bb1dcc8a24bf8950c79ee7ff517fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e05bb1dcc8a24bf8950c79ee7ff517fc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e05bb1dcc8a24bf8950c79ee7ff517fc2021-12-02T16:04:30ZMessenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice10.1038/s41541-021-00345-02059-0105https://doaj.org/article/e05bb1dcc8a24bf8950c79ee7ff517fc2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00345-0https://doaj.org/toc/2059-0105Abstract Human malaria affects the vast majority of the world’s population with the Plasmodium falciparum species causing the highest rates of morbidity and mortality. With no licensed vaccine and leading candidates achieving suboptimal protection in the field, the need for an effective immunoprophylactic option continues to motivate the malaria research community to explore alternative technologies. Recent advances in the mRNA discipline have elevated the long-neglected platform to the forefront of infectious disease research. As the immunodominant coat protein of the invasive stage of the malaria parasite, circumsporozoite protein (PfCSP) was selected as the antigen of choice to assess the immunogenic and protective potential of an mRNA malaria vaccine. In mammalian cell transfection experiments, PfCSP mRNA was well expressed and cell associated. In the transition to an in vivo murine model, lipid nanoparticle (LNP) encapsulation was applied to protect and deliver the mRNA to the cell translation machinery and supply adjuvant activity. The immunogenic effect of an array of factors was explored, such as formulation, dose, number, and interval of immunizations. PfCSP mRNA-LNP achieved sterile protection against infection with two P. berghei PfCSP transgenic parasite strains, with mRNA dose and vaccination interval having a greater effect on outcome. This investigation serves as the assessment of pre-erythrocytic malaria, PfCSP mRNA vaccine candidate resulting in sterile protection, with numerous factors affecting protective efficacy, making it a compelling candidate for further investigation.Katherine L. MalloryJustin A. TaylorXiaoyan ZouIshita N. WaghelaCosette G. SchneiderMichael Q. SibiloNeeraja M. PundeLeah C. PerazzoTatyana SavranskyMartha SedegahSheetij DuttaChris J. JanseNorbert PardiPaulo J. C. LinYing K. TamDrew WeissmanEvelina AngovNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Katherine L. Mallory Justin A. Taylor Xiaoyan Zou Ishita N. Waghela Cosette G. Schneider Michael Q. Sibilo Neeraja M. Punde Leah C. Perazzo Tatyana Savransky Martha Sedegah Sheetij Dutta Chris J. Janse Norbert Pardi Paulo J. C. Lin Ying K. Tam Drew Weissman Evelina Angov Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice |
description |
Abstract Human malaria affects the vast majority of the world’s population with the Plasmodium falciparum species causing the highest rates of morbidity and mortality. With no licensed vaccine and leading candidates achieving suboptimal protection in the field, the need for an effective immunoprophylactic option continues to motivate the malaria research community to explore alternative technologies. Recent advances in the mRNA discipline have elevated the long-neglected platform to the forefront of infectious disease research. As the immunodominant coat protein of the invasive stage of the malaria parasite, circumsporozoite protein (PfCSP) was selected as the antigen of choice to assess the immunogenic and protective potential of an mRNA malaria vaccine. In mammalian cell transfection experiments, PfCSP mRNA was well expressed and cell associated. In the transition to an in vivo murine model, lipid nanoparticle (LNP) encapsulation was applied to protect and deliver the mRNA to the cell translation machinery and supply adjuvant activity. The immunogenic effect of an array of factors was explored, such as formulation, dose, number, and interval of immunizations. PfCSP mRNA-LNP achieved sterile protection against infection with two P. berghei PfCSP transgenic parasite strains, with mRNA dose and vaccination interval having a greater effect on outcome. This investigation serves as the assessment of pre-erythrocytic malaria, PfCSP mRNA vaccine candidate resulting in sterile protection, with numerous factors affecting protective efficacy, making it a compelling candidate for further investigation. |
format |
article |
author |
Katherine L. Mallory Justin A. Taylor Xiaoyan Zou Ishita N. Waghela Cosette G. Schneider Michael Q. Sibilo Neeraja M. Punde Leah C. Perazzo Tatyana Savransky Martha Sedegah Sheetij Dutta Chris J. Janse Norbert Pardi Paulo J. C. Lin Ying K. Tam Drew Weissman Evelina Angov |
author_facet |
Katherine L. Mallory Justin A. Taylor Xiaoyan Zou Ishita N. Waghela Cosette G. Schneider Michael Q. Sibilo Neeraja M. Punde Leah C. Perazzo Tatyana Savransky Martha Sedegah Sheetij Dutta Chris J. Janse Norbert Pardi Paulo J. C. Lin Ying K. Tam Drew Weissman Evelina Angov |
author_sort |
Katherine L. Mallory |
title |
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice |
title_short |
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice |
title_full |
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice |
title_fullStr |
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice |
title_full_unstemmed |
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice |
title_sort |
messenger rna expressing pfcsp induces functional, protective immune responses against malaria in mice |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/e05bb1dcc8a24bf8950c79ee7ff517fc |
work_keys_str_mv |
AT katherinelmallory messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT justinataylor messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT xiaoyanzou messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT ishitanwaghela messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT cosettegschneider messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT michaelqsibilo messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT neerajampunde messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT leahcperazzo messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT tatyanasavransky messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT marthasedegah messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT sheetijdutta messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT chrisjjanse messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT norbertpardi messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT paulojclin messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT yingktam messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT drewweissman messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice AT evelinaangov messengerrnaexpressingpfcspinducesfunctionalprotectiveimmuneresponsesagainstmalariainmice |
_version_ |
1718385239548493824 |